Updated Jul 16, 2026
Kordasiewicz Holly B. has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.50M.

Holly B. Kordasiewicz serves as Executive Vice President and Chief Development Officer of Ionis Pharmaceuticals. In this role, she oversees Ionis' development strategy for antisense therapies and leads the company's clinical development initiatives. An SEC filing dated 2026-01-21 lists her as an insider with Ionis and notes no reported purchases or sales in that filing period.
| Role | EVP, Chief Development Officer |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 362 | $84.30 | $31K |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 19.8K | $74.05 | $1.47M |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | S — Open-market sale | 41.0K | $73.09 | $3.00M |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 19.9K | $56.78 | $1.13M |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 12.0K | $32.60 | $391K |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 21.0K | $60.89 | $1.28M |
| 2026-06-16 | IONS | IONIS PHARMACEUTICALS INC | M — Option exercise | 8.0K | $60.89 | $484K |
Holly B. Kordasiewicz serves as Executive Vice President and Chief Development Officer of Ionis Pharmaceuticals. In this role, she oversees Ionis' development strategy for antisense therapies and leads the company's clinical development initiatives. An SEC filing dated 2026-01-21 lists her as an insider with Ionis and notes no reported purchases or sales in that filing period.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($4.50M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kordasiewicz Holly B. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.